Top Markets
#1 Helium Helium +56.17%
#2 GEKKO GEKKO +53.94%
#3 ADO Protocol ADO Protocol +38.93%
#4 TENDIES TENDIES +37.05%
#5 Pons Pons +36.07%
#6 StonkBroker StonkBroker +32.23%
#7 Collector Crypt Collector Crypt +30.65%
#8 Prom Prom +28.49%
#9 o1.exchange o1.exchange +22.87%
#10 龙虾 (Lobster) 龙虾 (Lobster) +20.71%
Coin of the day
Helium Helium
Setări
Limbă
ROMâNă
Monedă
USD
Temă
Gubra A/S Gubra A/S

Gubra A/S

GUBRA
Rang în acțiuni #9438
Gubra A/S is a biotechnology firm engaged in two core activities: offering... Gubra A/S is a biotechnology firm engaged in two core activities: offering contract research organization (CRO) services for pre-clinical development, and advancing its own internal early-stage drug and target discovery initiatives. Its CRO division provides specialized pre-clinical research and development support to companies in the pharmaceutical and biotechnology sectors. These services encompass a wide range of capabilities, including in vivo pharmacology, tissue analysis, various assay development, molecular pharmacology, bioanalytical testing, next-generation sequencing (NGS), and both two-dimensional and three-dimensional imaging techniques. Established in 2008, the company has its headquarters in Horsholm, Denmark.
Preț acțiune
$61.73
Ultima sincronizare: 2026-08-28
Capitalizare de piață
$1.01B
Schimbare (1 zi)
-1.02%
Schimbare (1 an)
5.10%
Țară
DK
Tranzacționează Gubra A/S (GUBRA)

Categorie

Healthcare
Venituri pentru Gubra A/S (GUBRA)
Venituri în Aug 2026 TTM: 0
Conform celor mai recente rapoarte financiare ale Gubra A/S, venitul actual al companiei (TTM) este 0. În anul 2026, compania a avut un venit de 0 egal cu venitul din anul 2026, care a fost de 0. Venitul reprezintă suma totală generată de o companie din vânzarea de bunuri sau servicii. Spre deosebire de profit, cheltuielile nu sunt scăzute.
Istoricul veniturilor pentru Gubra A/S din 2026 până în 2026
Venituri la sfârșitul fiecărui an
An Venituri Schimbă
Nu sunt suficiente date pentru perioada selectată.
Venituri pentru companii similare sau concurente
Companie Venituri Diferență de venituri Țara
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $12.62B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $6.02B -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $15.74B -
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $2.23B -
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH